Press Releases

South African Government

The Minister and Deputy Minister of Science, Technology and Innovation, Professor Blade Nzimande and Dr Nomalungelo Gina, today announced a R10.4 billion budget for the 2026/2027 financial year, showing continued investment in priority areas of...

GlobeNewswire, Inc.

– Complete response (CR) observed in 70% (50/72) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who completed Primary Response Evaluation (PRE) – – Updated durability data shows 85.7% (18/21) of patients who completed...

GlobeNewswire, Inc.

TARRYTOWN, N.Y. and WASHINGTON, May 15, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc., and Society for Science (the Society) announced that Hikaru Kuribayashi, 17, of Sapporo, Japan won the $100,000 George D. Yancopoulos Innovator Award...

GlobeNewswire, Inc.

TARRYTOWN, N.Y. and WASHINGTON, May 15, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc., and Society for Science (the Society) announced that Hikaru Kuribayashi, 17, of Sapporo, Japan won the $100,000 George D. Yancopoulos Innovator Award...

GlobeNewswire, Inc.

Vancouver, BC, May 15, 2026 (GLOBE NEWSWIRE) -- SalesCloser Technologies Ltd. (“SalesCloser” or the “Company”) (TSXV: SCAI) (FSE: MJ5), a pioneer in autonomous AI sales technology, announces the commissioning of a dedicated AI inference cluster...

GlobeNewswire, Inc.

Hikaru Kuribayashi, 17, receives $100,000 Top Award for his creation of a simulation program to understand complex folding at the world’s largest pre-college STEM competition.

EIN Presswire

Following its December release, Energetic First Principles opens a 90-day public review inviting independent evaluation, replication, and constructive feedback.

GlobeNewswire, Inc.

SALT LAKE CITY, May 13, 2026 (GLOBE NEWSWIRE) -- WGU, the largest conferrer of technology degrees in the U.S., announced today the launch the nation’s first accredited, competency-based Bachelor of Science in AI Engineering (BSAIE), also among the...

GlobeNewswire, Inc.

SAN DIEGO, May 15, 2026 (GLOBE NEWSWIRE) -- Recludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today presented preclinical data for REX-8756 demonstrating...

EIN Presswire

Color Memory Game launches at colormemorygame.com, a quick, science-inspired challenge that most players fail on their first try. LA, CA, UNITED STATES, May 15, 2026 /⁨EINPresswire.com⁩/ -- Color Memory Game, a free browser-based perception game,...

GlobeNewswire, Inc.

WILLOWBROOK, Ill., May 14, 2026 (GLOBE NEWSWIRE) -- Pharmazz, Inc. today announced the appointment of Ajay Bansal as Chief Financial Officer, effective immediately.

GlobeNewswire, Inc.

QIND Achieves Positive Net Income and Operating Income While Reducing Operating Expenses by Approximately 56.6% Year-Over-Year Al Shola Gas Awarded 16 New Engineering Subcontracts Subsequent to Quarter-End with Aggregate Expected Value of...

GlobeNewswire, Inc.

SEATTLE , May 15, 2026 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has sold an aggregate of 21,607,878 shares of the...

GlobeNewswire, Inc.

New Taipei City, Taiwan, May 15, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization of innovative plant-derived...

GlobeNewswire, Inc.

WASHINGTON, May 15, 2026 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, today reported its financial results for the...

GlobeNewswire, Inc.

NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD), today announced new data shared at the Music City SCALE meeting taking...

GlobeNewswire, Inc.

Completed enrollment in first cohort of Phase 1b challenge study evaluating CDI-988 as a preventive and as a treatment for norovirus infection, began enrollment in prevention and treatment cohorts Highlighted CDI-988’s mechanism of action and...

GlobeNewswire, Inc.

Company to continue development of efzofitimod in pulmonary sarcoidosis following Type C meeting with the FDA. Company plans to submit an IND in June 2026 for a Phase 3 study of efzofitimod in patients with chronic, symptomatic pulmonary...

GlobeNewswire, Inc.

CHENGDU, China and ROCKAWAY, N.J., May 15, 2026 (GLOBE NEWSWIRE) -- Kanghong Pharmaceutical and Vanotech Ltd. today announced the successful completion of a Phase 2b clinical trial evaluating KH607 in adults with major depressive disorder (MDD)....

GlobeNewswire, Inc.

New data from IM1240 (capped-CD3 × 5T4 × NKG2A) tri-specific antibody demonstrated potent anti-tumor activity across all treatment-resistant patient-derived tumor samples Established CAPTN-3 Scientific Advisory Board with leading experts in T-cell...